Spectrum: Autism Research News

Autistic researchers describe the challenges they’ve faced in academia and how their non-autistic colleagues can make the workplace more inclusive.

Here is a roundup of news and research for the week of 29 August.

Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.

Many brain regions develop differently between people with 22q11.2 duplications and deletions, and those trajectories also vary with a person’s diagnosis.

What these genes do and how they affect autism depends on when in development they’re studied, despite what classic ‘gene ontology’ analyses say.

Here is a roundup of news and research for the week of 15 August.

Here is a roundup of news and research for the week of 8 August.

Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Through a website called Stories of Women in Neuroscience, Nancy Padilla-Coreano aims to shift biases in the field, one conversation at a time.

People’s brains have a larger network of inhibitory interneurons than mouse brains do, according to a new study. Changes to that network could contribute to autism or other conditions, says lead investigator Moritz Helmstaedter.